DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Acutaas Chemicals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 18 hrs ago·20 Jul 2026, 6:17 am

Acutaas Chemicals

Acutaas Chemicals Limited has announced that it will hold an institutional investor meeting on July 24, 2026. This event is scheduled for 4:00 PM IST and is intended to facilitate discussions with analysts and institutional investors. The company has informed the stock exchanges about this upcoming engagement.

For investors, this meeting is a key opportunity to gain direct insights into the company's future strategy and operational outlook. It allows the management to address queries and potentially share updates on business performance and expansion plans. Monitoring the company's official disclosures following the event will be crucial for understanding the market's reaction and any new information shared during the discussion.

Investors should watch for any specific guidance or commentary regarding the company's growth trajectory. This information will be vital for assessing the stock's potential and making informed investment decisions based on the latest developments from the management.